뉴스

• [K-Bio Pulse]Biotech Stocks Defy 'Black Tuesday' as MedPacto Soars, Bioinfra Faces Dead... Despite the "Black Tuesday" selloff on July 28, several biotech stocks bucked the broader market. As the Kosdaq tumbled, Cellid, Bioinfra, and MedPacto all hit www.edaily.co.kr · 2026.07.29
• FromBio Hits Limit-Up as Trading Resumes; Curacle Surges on Follow-On Licensing Hopes [K-Bio Puls... On Aug. 10, South Korean pharmaceutical and biotech stocks broadly advanced as the KOSDAQ rebounded. FromBio soared to the daily upper limit as trading resumed www.edaily.co.kr · 2026.08.11
• Remedi Surges, HLB Hits Limit Down as FDA Blow Weighs[K-Bio Pulse] The Korean biotech sector saw sharply diverging performances on July 13, with newly listed Remedi. emerging as the day's standout performer, while HLB extended www.edaily.co.kr · 2026.07.14
• BL Pharmtech Shares Hit Upper Limit as Expectations Grow for Technology Transfer Deal[K-Bio Pulse... On June 18, shares of BL PharmTech, JLK, and Raphas stood out in the domestic pharmaceutical and biotechnology stock market with strong gains. In particular, BL www.edaily.co.kr · 2026.06.21
• [WT논평] Iran is trying to turn America against Israel(Ⅲ) Hezbollah terrorists will start firing again, as they always do; as Iran k www.segye.com · 2026.06.30
• [시론] 독파모 2차 평가를 보고...남은 과제는 공개된 문제 유형에 맞춘 합성데이터를 집중적으로 생성하거나 후학습을 최적화하고, LLM-as-a-Judge가 선호하는 답변 형태를 학습하는 이른바 벤치맥싱(Bench-maxing) K-EXAONE 2.0은 31점이었다. 16점이라는 격차는 결코 작지 않다. 글로벌 벤치마크만 놓고 보면 상당한 차이다. zdnet.co.kr · 2026.08.19
• [박준성의 SW] 한국 SW개발, 미국 1990년대...AI강국 걸림돌 Jacobson 등의 The Unified Software Development Process(1998), K. Beck의 Extreme Programming Explained(1999), K. Schwaber와 M. zdnet.co.kr · 2026.08.16